Welcome to our dedicated page for Danone news (Ticker: DANOY), a resource for investors and traders seeking the latest updates and insights on Danone stock.
The news page for Danone S.A. (DANOY) aggregates company announcements and market-relevant updates for this global food and beverage group. Danone’s releases provide insight into its three core categories—Essential Dairy & Plant-Based products, Waters and Specialized Nutrition—as well as its broader Renew strategy, which it describes as focused on restoring growth, competitiveness and long-term value creation.
Investors and observers can use Danone news to follow developments such as quarterly sales updates, geographic and category performance, and details on like-for-like growth, volume/mix and pricing trends. Danone’s communications also cover acquisitions and strategic investments, including moves in gut health, microbiome science and plant-based nutrition that support its health-focused positioning.
Capital markets and balance sheet actions feature regularly in Danone’s news flow. Examples include dual-tranche bond issues, with explanations of how proceeds will be used and how instruments are treated under IFRS and by credit rating agencies, as well as share buyback mandates and transactions involving the company’s own shares. Danone also publishes recurring notices on its total number of shares and voting rights, in line with French regulatory requirements.
Corporate governance and organizational updates are another theme, with announcements on changes to leadership structure and geographic organization, such as the shift to EMEA, Asia Pacific and Americas. For those tracking DANOY, this news stream offers context on Danone’s operational performance, strategic priorities and capital structure. Bookmark this page to review new press releases and regulatory communications as they are published.
Danone reported its FY 2020 results, showing a net sales decline of 1.5% like-for-like, totaling €23.62bn. Despite challenges from COVID-19, Essential Dairy and Plant-based (EDP) grew 3.4%, while Specialized Nutrition and Waters faced significant headwinds. Recurring EPS fell 13% to €3.34, although reported EPS rose 1.2% to €2.99. A €1bn savings plan is in place to support innovation and brand growth. The company anticipates recovery in Q2 2021, with FY recurring operating margin expected to align with 2020 levels. Additionally, Danone announced plans to acquire Follow Your Heart, enhancing its plant-based portfolio.
Danone disclosed the total number of voting rights and shares as of January 31, 2021. The company reported a total of 686,629,600 shares and 712,722,584 theoretical voting rights, with 675,888,894 exercisable voting rights. This information complies with French regulations, ensuring transparency in shareholding thresholds. The distinction between theoretical and exercisable voting rights is highlighted, where the former includes shares with suspended voting rights.
Danone reported Q3 2020 sales at €5,821 million, a decline of -9.3% year-over-year (YoY) and -2.5% on a like-for-like basis. The company aims for a 14% recurring operating margin and €1.8 billion in free cash flow for FY 2020. Key changes include the appointment of two new macro-regional CEOs and the launch of a portfolio review to enhance growth strategies. Despite challenges, sales in Essential Dairy and Plant-based segments grew by +3.7%. The company braces for uncertainty due to COVID-19's impact on consumer behavior and channel dynamics.
Danone has completed the sale of its 6.61% stake in Yakult Honsha Co. Ltd. for a total gross consideration of JPY58 billion (approximately €470 million). This strategic move is expected to enhance Danone's balance sheet significantly. The transaction settlement is set for October 9, 2020. This divestiture aligns with Danone's health-focused business strategy and commitment to sustainable growth across its diverse product portfolio, which includes essential dairy and plant-based products.
Danone announces the sale of its remaining 6.61% stake in Yakult Honsha Co. Ltd. through an accelerated bookbuilding process. This decision aligns with Danone's commitment to capital allocation discipline and strengthening its balance sheet. Despite this divestment, both companies reaffirm their long-term collaboration on probiotics, including existing partnerships in India and Vietnam. Danone's previous stake was 21.29%, most of which was sold in 2018. Further details regarding the sale's success will be disclosed shortly.
Danone has released a report detailing the total number of shares and voting rights as of September 30, 2020. The company has 686,629,600 shares outstanding, with theoretical voting rights totaling 712,743,160 and exercisable voting rights at 675,901,143. This disclosure complies with Article L. 233-8 II of the French Commercial Code and Article 223-16 of the Financial Markets Authority regulations, ensuring transparency in shareholding thresholds.